In a start up pre clinical biotechnology I think i

In a start up pre clinical biotechnology I think it's important to be patient w shareholders and sensitive to their fears bc they are the ones giving you an opportunity to become an Amgen they are taking a major financial risk to finance and make possible for management's visions to come to fruition. At this stage with so many unknowns I think gerald going out of his way to communicate w true longs is commendable and respectable because it's not mandatory.